Literature DB >> 24467818

Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.

Takaaki Wakamori1, Takashi Agari2, Takao Yasuhara1, Masahiro Kameda1, Akihiko Kondo1, Aiko Shinko1, Susumu Sasada1, Tatsuya Sasaki1, Tomohisa Furuta3, Isao Date1.   

Abstract

OBJECTIVE: We wished to relate severity of Parkinson's disease (PD) with cognitive function in relation to cerebral blood flow (CBF).
METHODS: Eighty-one consecutive PD patients were enrolled in this study. We used Mini-Mental State Examination (MMSE) and Wechsler Adult Intelligence Scale-Third edition (WAIS-III) to evaluate cognitive functions, and three-dimensional stereotactic ROI template (3DSRT) and Statistical Parametric Mapping (SPM) 8 to evaluate single photon emission CT (SPECT) recordings of regional CBF.
RESULTS: The mean MMSE score of PD patients was 27.4 ± 2.4. The scores of most patients were higher than 23/30. On the other hand, the mean Full-scale IQ of PD patients was 88.4 ± 17.3 in WAIS-III, which was lower than that of normal controls. In particular, visuospatial function score of most patients was lower. There was significant correlation between cognitive scores and Hoehn & Yahr stage and hallucinatory episodes. PD Patients with stage III and IV showed significant deterioration in cognitive functions compared to stage II patients. Analysis of CBF revealed relative reductions in perfusion in the cerebral cortex relative to that in normal control. SPM 8 showed that cognitive functions in PD patients were positively correlated with rCBF in the thalamus and cingulate gyrus.
CONCLUSIONS: This is the study to demonstrate the cognitive impairments in PD patients using WAIS-III. Visuospatial dysfunction might be caused by decrease in rCBF in the parietal and occipital lobes and dorsolateral prefrontal cortex. The severity of cognitive impairments in PD patients was correlated with disease severity and hallucinatory episodes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive functions; Disease severity; Hallucinations; Parkinson's disease; SPECT

Mesh:

Year:  2014        PMID: 24467818     DOI: 10.1016/j.parkreldis.2014.01.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

Review 1.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

2.  Multidelay multiparametric arterial spin labeling perfusion MRI and mild cognitive impairment in early stage Parkinson's disease.

Authors:  Xueling Suo; Du Lei; Lan Cheng; Nannan Li; Panli Zuo; Danny J J Wang; Xiaoqi Huang; Su Lui; Graham J Kemp; Rong Peng; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2018-12-07       Impact factor: 5.038

3.  Combined Diffusion Tensor Imaging and Arterial Spin Labeling as Markers of Early Parkinson's disease.

Authors:  Xiaobo Wei; Ronghua Yan; Zhaoyu Chen; Ruihui Weng; Xu Liu; Huimin Gao; Xiaofeng Xu; Zhuang Kang; Zhexing Liu; Yan Guo; Zhenhua Liu; Jan Petter Larsen; Jin Wang; Beisha Tang; Mark Hallett; Qing Wang
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

4.  Meta-analytic Evidence for the Plurality of Mechanisms in Transdiagnostic Structural MRI Studies of Hallucination Status.

Authors:  Colleen P E Rollins; Jane R Garrison; Jon S Simons; James B Rowe; Claire O'Callaghan; Graham K Murray; John Suckling
Journal:  EClinicalMedicine       Date:  2019-02-21

5.  Metabolite changes in prefrontal lobes and the anterior cingulate cortex correlate with processing speed and executive function in Parkinson disease patients.

Authors:  Chentao He; Siming Rong; Piao Zhang; Ruitao Li; Xiaohong Li; Yan Li; Lijuan Wang; Yuhu Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-08

Review 6.  Cell Therapy for Parkinson's Disease.

Authors:  Takao Yasuhara; Masahiro Kameda; Tatsuya Sasaki; Naoki Tajiri; Isao Date
Journal:  Cell Transplant       Date:  2017-09       Impact factor: 4.064

7.  Neurophysiological Biomarkers of Parkinson's Disease.

Authors:  Shani Waninger; Chris Berka; Marija Stevanovic Karic; Stephanie Korszen; P David Mozley; Claire Henchcliffe; Yeona Kang; Jacob Hesterman; Tomer Mangoubi; Ajay Verma
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.